TMEM49 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.782200E-01
Normal-vs-Stage2
3.135600E-01
Normal-vs-Stage3
8.098600E-01
Normal-vs-Stage4
4.248000E-01
Stage1-vs-Stage2
1.498630E-01
Stage1-vs-Stage3
8.313400E-01
Stage1-vs-Stage4
3.385400E-01
Stage2-vs-Stage3
1.780040E-01
Stage2-vs-Stage4
7.942600E-01
Stage3-vs-Stage4
3.366400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.030000E-01
Normal-vs-AfricanAmerican
3.857600E-01
Normal-vs-Asian
2.619600E-01
Caucasian-vs-AfricanAmerican
5.966800E-01
Caucasian-vs-Asian
4.754600E-01
AfricanAmerican-vs-Asian
3.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.605600E-01
Normal-vs-Female
4.240600E-01
Male-vs-Female
5.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.198600E-01
Normal-vs-Age(41-60Yrs)
2.353000E-01
Normal-vs-Age(61-80Yrs)
4.731600E-01
Normal-vs-Age(81-100Yrs)
3.693000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.557600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.526000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.541000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.506100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.206400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.362000E-01
Normal-vs-Daily Drinker
4.440200E-01
Normal-vs-Weekly Drinker
4.566000E-01
Normal-vs-Occasional Drinker
4.826000E-01
Normal-vs-Social Drinker
2.731800E-01
Non Drinker-vs-Daily Drinker
8.998600E-01
Non Drinker-vs-Weekly Drinker
9.483000E-01
Non Drinker-vs-Occasional Drinker
8.338400E-01
Non Drinker-vs-Social Drinker
1.532570E-01
Daily Drinker-vs-Weekly Drinker
9.665200E-01
Daily Drinker-vs-Occasional Drinker
9.275800E-01
Daily Drinker-vs-Social Drinker
1.940010E-01
Weekly Drinker-vs-Occasional Drinker
9.051400E-01
Weekly Drinker-vs-Social Drinker
2.382200E-01
Occasional Drinker-vs-Social Drinker
1.640020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.536800E-01
Normal-vs-Grade 2
1.685540E-02
Normal-vs-Grade 3
6.874400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.298410E-01
Grade 1-vs-Grade 3
1.270160E-02
Grade 1-vs-Grade 4
2.536800E-01
Grade 2-vs-Grade 3
6.218300E-02
Grade 2-vs-Grade 4
1.685540E-02
Grade 3-vs-Grade 4
6.874400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.533600E-01
Normal-vs-NonDiabetic
3.625600E-01
Diabetic-vs-NonDiabetic
1.658230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.474100E-02
Normal-vs-NoPancreatitis
4.745000E-01
Pancreatitis-vs-NoPancreatitis
1.741220E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.689600E-01
Normal-vs-N1
3.677800E-01
N0-vs-N1
7.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.137200E-01
Normal-vs-TP53-NonMutant
8.985600E-01
TP53-Mutant-vs-TP53-NonMutant
2.906500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
